Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Will artificial intelligence make statisticians obsolete—or make our expertise even more valuable?
In this episode, I speak with independent statistical consultant Chris Harbron about how AI could reshape the role of statisticians in the pharmaceutical industry. Our conversation builds on Chris’s paper, Will the Pharmaceutical Industry Need Statisticians in an AI World?
We explore what happens when AI generates protocols, statistical analysis plans, programs, and reports. We also discuss why producing a plausible document differs from making sound decisions about clinical development.
Chris and I examine the areas where human statisticians continue to add essential value—from navigating trade-offs and challenging assumptions to building trust and accepting accountability. We also share practical ways statisticians can begin working with AI while protecting quality, scientific rigor, and authenticity.
